Literature DB >> 22112485

Hepatocellular carcinoma of the liver.

Timothy Block1, Anand S Mehta, W Thomas London.   

Abstract

Primary cancer of the liver, hepatocellular carcinoma (HCC), is an extremely deadly cancer, with very poor 5 year survivals, following diagnosis. The poor outcomes are believed to be due, in part, to the late times in which the cancers are usually first detected. Improved methods for early detection have thus become a top priority in the management of liver cancer. This Chapter reviews current methods of detection as well as leading new methods. Possible explanations as to why there are so many markers that are being discovered, but so few that make it to validation are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22112485     DOI: 10.3233/CBM-2011-0165

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  6 in total

1.  Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.

Authors:  Tianxiang Ge; Qiujin Shen; Ning Wang; Yurong Zhang; Zhouhong Ge; Wei Chu; Xiufang Lv; Fengbo Zhao; Weifeng Zhao; Jia Fan; Wenxin Qin
Journal:  Med Oncol       Date:  2015-02-06       Impact factor: 3.064

2.  Expression of MSP58 in hepatocellular carcinoma.

Authors:  Ming Zhong; Xi Zhang; Bing Li; Chang-sheng Chen; Gen-lin Ji; Shi-xing Li; Dan-qing Bi; Qing-chuan Zhao; Hai Shi
Journal:  Med Oncol       Date:  2013-03-22       Impact factor: 3.064

Review 3.  Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma.

Authors:  Ranjit Chauhan; Nivedita Lahiri
Journal:  Biomark Cancer       Date:  2016-07-04

4.  Knockdown of Decoy Receptor 3 Impairs Growth and Invasiveness of Hepatocellular Carcinoma Cell Line of HepG2.

Authors:  Xiao-Na Zhou; Guang-Ming Li; Ying-Chen Xu; Tuan-Jie Zhao; Ji-Xiang Wu
Journal:  Chin Med J (Engl)       Date:  2016-11-05       Impact factor: 2.628

5.  Improving the Detection of Hepatocellular Carcinoma Using Serum AFP Expression in Combination with GPC3 and Micro-RNA MiR-122 Expression.

Authors:  Jian Li; Sun Qiyu; Tiezheng Wang; Boxun Jin; Ning Li
Journal:  Open Life Sci       Date:  2019-03-20       Impact factor: 0.938

6.  MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.

Authors:  Moustafa Nouh Elemeery; Marwa Anwar Mohamed; Marwa Ahmed Madkour; Mohammed Mohammed Shamseya; Noha Mahmoud Issa; Ahmed Noah Badr; Doaa Ahmed Ghareeb; Cheol-Ho Pan
Journal:  World J Gastroenterol       Date:  2019-11-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.